Effects of drotrecogin alfa (activated) in human endotoxemia.

Shock (Augusta, Ga.)

Volumn 21, Issue 3, 2004, Pages 222-229

  Kalil, Andre C ^a   Coyle, Susette M ^a   Um, John Y ^a   LaRosa, Steven P ^a   Turlo, Mary Ann ^a   Calvano, Steve E ^a   Sundin, David P ^a   Nelson, David R ^a   Lowry, Stephen F ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DROTRECOGIN; ENDOTOXIN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PROTEIN C; RECOMBINANT PROTEIN; THROMBIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE; CELL MEMBRANE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENDOTOXEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBRINOLYSIS; HUMAN; INFLAMMATION; METABOLISM; RANDOMIZED CONTROLLED TRIAL; SEPSIS; TIME; VASCULAR ENDOTHELIUM;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD PRESSURE; CELL MEMBRANE; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; ENDOTOXEMIA; ENDOTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRINOLYSIS; HUMANS; INFLAMMATION; PLACEBOS; PROTEIN C; RECOMBINANT PROTEINS; SEPSIS; THROMBIN; TIME FACTORS;

EID: 3042571475     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000116778.27924.79     Document Type: Article

References (0)